loadpatents
name:-0.01488995552063
name:-0.0078630447387695
name:-0.0039632320404053
Hollenbach; Stanley J. Patent Filings

Hollenbach; Stanley J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hollenbach; Stanley J..The latest application filed is for "unit dose formulation of antidotes for factor xa inhibitors and methods of using the same".

Company Profile
3.8.13
  • Hollenbach; Stanley J. - South San Francisco CA
  • Hollenbach; Stanley J. - Raleigh NC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Unit Dose Formulation Of Antidotes For Factor Xa Inhibitors And Methods Of Using The Same
App 20210085762 - Sinha; Uma ;   et al.
2021-03-25
Compositions for treating inflammation and methods of treating the same
Grant 10,912,743 - Stasko , et al. February 9, 2
2021-02-09
Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same
Grant 10,765,726 - Sinha , et al. Sep
2020-09-08
MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTE
App 20200129597 - Hollenbach; Stanley J. ;   et al.
2020-04-30
Compositions For Treating Inflammation And Methods Of Treating The Same
App 20190015358 - Stasko; Nathan ;   et al.
2019-01-17
Unit Dose Formulation Of Antidotes For Factor Xa Inhibitors And Methods Of Using The Same
App 20180236049 - Sinha; Uma ;   et al.
2018-08-23
MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTE
App 20180185459 - Hollenbach; Stanley J. ;   et al.
2018-07-05
Unit Dose Formulation Of Antidotes For Factor Xa Inhibitors And Methods Of Using The Same
App 20170014492 - Sinha; Uma ;   et al.
2017-01-19
Modulation Of Factor Xa Inhibitor Mediated Blood Loss By Partial And Transient Administration Of Antidote
App 20160015793 - HOLLENBACH; STANLEY J. ;   et al.
2016-01-21
Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same
Grant 9,056,106 - Sinha , et al. June 16, 2
2015-06-16
Unit Dose Formulation Of Antidotes For Factor Xa Inhibitors And Methods Of Using The Same
App 20150025011 - SINHA; UMA ;   et al.
2015-01-22
Combination Anticoagulant Therapy With A Compound That Acts As A Factor Xa Inhibitor
App 20130315897 - Sinha; Uma ;   et al.
2013-11-28
Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor
Grant 8,455,440 - Sinha , et al. June 4, 2
2013-06-04
Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor
Grant 8,404,724 - Sinha , et al. March 26, 2
2013-03-26
Combination Anticoagulant Therapy With A Compound That Acts As A Factor Xa Inhibitor
App 20120046230 - Sinha; Uma ;   et al.
2012-02-23
Unit Dose Formulation Of Antidotes For Factor Xa Inhibitors And Methods Of Using The Same
App 20110015128 - SINHA; UMA ;   et al.
2011-01-20
Combination Anticoagulant Therapy With A Compound That Acts As A Factor Xa Inhibitor
App 20080254036 - Sinha; Uma ;   et al.
2008-10-16
Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor
App 20080153876 - Sinha; Uma ;   et al.
2008-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed